Educational content only — this is not medical advice. Nothing here is a recommendation to buy, obtain, or use Matrixyl 3000. Talk to a licensed clinician before making health decisions.
What it is
Matrixyl 3000 combines two peptides: palmitoyl tripeptide-1 (Pal-GHK), a collagen fragment analog, and palmitoyl tetrapeptide-7 (Pal-GQPR), which is proposed to reduce interleukin-6 production. The combination is intended to stimulate matrix remodeling while calming inflammation.
What the evidence shows
Manufacturer-sponsored and independent small cosmetic studies report improvements in wrinkle depth, skin elasticity, and tone after 8–12 weeks. As with other cosmetic peptides, effects are modest and limited to appearance, not disease treatment.
Risks & unknowns
Topical use is generally well tolerated. Rarely, irritation or allergic contact dermatitis can occur.
Legal / regulatory status
Matrixyl 3000 is a cosmetic ingredient, not an FDA-approved drug.